FI962435A0 - N.N'-bis(2-hydroksibentsyyli)eteenidiamiini-N,N'-dietikkahapon johdannaiset kelatoivina aineina - Google Patents
N.N'-bis(2-hydroksibentsyyli)eteenidiamiini-N,N'-dietikkahapon johdannaiset kelatoivina aineinaInfo
- Publication number
- FI962435A0 FI962435A0 FI962435A FI962435A FI962435A0 FI 962435 A0 FI962435 A0 FI 962435A0 FI 962435 A FI962435 A FI 962435A FI 962435 A FI962435 A FI 962435A FI 962435 A0 FI962435 A0 FI 962435A0
- Authority
- FI
- Finland
- Prior art keywords
- hydroxybenzyl
- ethylenediamine
- bis
- acid derivatives
- chelating agents
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
- C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D317/34—Oxygen atoms
- C07D317/40—Vinylene carbonate; Substituted vinylene carbonates
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP93810886 | 1993-12-16 | ||
PCT/IB1994/000388 WO1995016663A1 (en) | 1993-12-16 | 1994-12-05 | N,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid derivatives as chelating agents |
Publications (2)
Publication Number | Publication Date |
---|---|
FI962435A0 true FI962435A0 (fi) | 1996-06-12 |
FI962435A FI962435A (fi) | 1996-06-12 |
Family
ID=8215091
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI962435A FI962435A (fi) | 1993-12-16 | 1996-06-12 | N.N'-bis(2-hydroksibentsyyli)eteenidiamiini-N,N'-dietikkahapon johdannaiset kelatoivina aineina |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0734374A1 (fi) |
JP (1) | JPH09507473A (fi) |
CN (1) | CN1137267A (fi) |
AU (1) | AU1033495A (fi) |
CA (1) | CA2179203A1 (fi) |
FI (1) | FI962435A (fi) |
HU (1) | HUT74457A (fi) |
NO (1) | NO962307L (fi) |
WO (1) | WO1995016663A1 (fi) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7026116B1 (en) | 1996-04-04 | 2006-04-11 | Bio-Rad Laboratories, Inc. | Polymorphisms in the region of the human hemochromatosis gene |
US6140305A (en) * | 1996-04-04 | 2000-10-31 | Bio-Rad Laboratories, Inc. | Hereditary hemochromatosis gene products |
AU2958397A (en) * | 1996-05-21 | 1997-12-09 | Novartis Ag | N,n'-di(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid derivatives |
US6849399B1 (en) | 1996-05-23 | 2005-02-01 | Bio-Rad Laboratories, Inc. | Methods and compositions for diagnosis and treatment of iron misregulation diseases |
EP1757614B1 (en) | 1997-06-13 | 2010-03-31 | Bio-Rad Laboratories, Inc. | Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
FR2768145B1 (fr) | 1997-09-09 | 1999-10-08 | Oreal | Nouveaux composes derives d'acide alkylene diamine di- ou tri-acetique, leur procede de preparation, leur utilisation dans des compositions cosmetiques et pharmaceutiques, et compositions les comprenant |
TR200002256T2 (tr) | 1998-02-04 | 2001-03-21 | University Of Florida Research Foundation, Inc. | Demir celatlama tedavisinde N,N' -BIS(2-Hidroksibenzil) etilendiamin-N, N'diasetik asit içeren farmasötikler. |
US6646157B2 (en) | 1999-12-21 | 2003-11-11 | Geltex Pharmaceuticals, Inc. | Method for making HBED |
CN109438517B (zh) * | 2018-12-27 | 2021-01-08 | 北京久杰净化工程技术有限公司 | 一种与羰基金属核心配位的双功能连接剂的配合物及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4528196A (en) * | 1981-02-23 | 1985-07-09 | The United States Of America As Represented By The Department Of Health And Human Services | Chelating agents for the treatment of iron overload |
DE69023394T2 (de) * | 1989-06-16 | 1996-07-04 | Merck Frosst Canada Inc | Chelat-Derivate von atrialnatriurethischem Faktor (ANF). |
-
1994
- 1994-12-05 AU AU10334/95A patent/AU1033495A/en not_active Abandoned
- 1994-12-05 CN CN94194494A patent/CN1137267A/zh active Pending
- 1994-12-05 HU HU9601658A patent/HUT74457A/hu unknown
- 1994-12-05 EP EP95900893A patent/EP0734374A1/en not_active Withdrawn
- 1994-12-05 WO PCT/IB1994/000388 patent/WO1995016663A1/en not_active Application Discontinuation
- 1994-12-05 CA CA002179203A patent/CA2179203A1/en not_active Abandoned
- 1994-12-05 JP JP7516635A patent/JPH09507473A/ja active Pending
-
1996
- 1996-06-04 NO NO962307A patent/NO962307L/no unknown
- 1996-06-12 FI FI962435A patent/FI962435A/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU1033495A (en) | 1995-07-03 |
HU9601658D0 (en) | 1996-08-28 |
WO1995016663A1 (en) | 1995-06-22 |
NO962307D0 (no) | 1996-06-04 |
FI962435A (fi) | 1996-06-12 |
CN1137267A (zh) | 1996-12-04 |
HUT74457A (en) | 1996-12-30 |
NO962307L (no) | 1996-06-04 |
CA2179203A1 (en) | 1995-06-22 |
EP0734374A1 (en) | 1996-10-02 |
JPH09507473A (ja) | 1997-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL300181I2 (nl) | N-(pyrroloÖÄ2,3-dÖÜpyrimidine-3-ylacyl)-glutaminezuurderivaten. | |
DE69010714D1 (de) | Stückförmiges Waschmittel. | |
ATA236185A (de) | Waesseriges, thixotropes waschmittel | |
TR199501261A2 (tr) | Aminler ve anyonik yüzeyaktif maddeler ihtiva eden deterjan bilesimleri. | |
MA23136A1 (fr) | Composition de nettoyage comprenant des tensio- actifs a courte chaine . | |
FI954255A0 (fi) | 2,9-diamino- ja 2-amino-8-karbaomyyli-4-hydroksi-alkaanihappoamidijohdannaiset | |
TR26910A (tr) | Konsantre, sulu sivi deterjan bilesimleri. | |
ZA979834B (en) | Ethylenediaminetriacetic acid and N-acyl ethylenediaminetriacetic acid silver chelating agents and surfactants. | |
ATA236085A (de) | Waesseriges, thixotropes waschmittel | |
FI962435A0 (fi) | N.N'-bis(2-hydroksibentsyyli)eteenidiamiini-N,N'-dietikkahapon johdannaiset kelatoivina aineina | |
NL1001517A1 (nl) | Koppeling. | |
AU2456201A (en) | N,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid in iron chelating therapy | |
NO913919L (no) | Vandig, tiksotropisk vaskemiddelblanding. | |
NL1001617C2 (nl) | Koppeling. | |
DE59301060D1 (de) | Substituierte Aminosäureamide. | |
FI941149A (fi) | 2,4-diamino-3-hydroksikarboksyylihapon johdannaisia | |
AU2958397A (en) | N,n'-di(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid derivatives | |
BR9408162A (pt) | Derivados de ácido 2,3,5,6-tetrafluorbenzóico | |
IT1267492B1 (it) | Composizione detergente. | |
TR199500943A2 (tr) | Deterjan bilesimleri. | |
FI945105A0 (fi) | 17alfa- ja 17beta-substituoitu estra-1,3,5(10)-trieeni-3-karboksyylihappo | |
NL192999B (nl) | Koppeling. | |
Jun et al. | Growth-cycle decomposed innovation diffusion model | |
ES1028019Y (es) | Esfera celeste local armilar perfeccionada. | |
IT8119746A0 (it) | N,n'-bis (2-idrossi-e 2,3-diidrossibenzoli)-d,w-di e triami-noalcani come prodotti farmaceutici per chelare il ferro attivi per via orale. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB | Transfer or assigment of application |
Owner name: NOVARTIS AG |
|
FD | Application lapsed |